You are here

Texas Hospitals Lead Workplace Wellness Effort

June 23, 2011
Cary, NC

Medical City Dallas Hospital and Austin-based Seton Healthcare Family have received CEO Cancer Gold Standard™ accreditation, recognizing their commitment to reducing cancer risk by promoting healthy lifestyle choices, encouraging early detection through cancer screenings, and ensuring access to quality treatment for their own employees and their covered family members. They join with MD Anderson Cancer Center in Houston as Texas-based hospitals providing leadership in workplace wellness efforts.

Christopher A. Viehbacher, chief executive officer of Sanofi, chairs the CEO Roundtable on Cancer, a nonprofit organization of cancer-fighting CEOs who created the CEO Cancer Gold Standard™, in collaboration with the National Cancer Institute, many of its designated cancer centers, and leading health non-profit organizations and professionals. Today, more than two million employees and family members are benefiting from the vision and leadership of employers like Medical City Dallas Hospital and the Seton Healthcare Family who have chosen to become Gold Standard accredited.

“We are pleased to recognize the efforts of Medical City Dallas Hospital and the Seton Healthcare Family in the fight against cancer, starting with improving the health and wellness of their own employees,” said Christopher A. Viehbacher, CEO of Sanofi.  “I hope their commitment will encourage other medical centers and all employers, large and small, to become Gold Standard accredited.”

The CEO Cancer Gold Standard™ calls for companies to evaluate their health benefits and corporate culture and take extensive, concrete actions in five key areas of health and wellness to fight cancer in the workplace. To earn Gold Standard accreditation, a company must establish programs to reduce cancer risk by discouraging tobacco use; encouraging physical activity; promoting healthy diet and nutrition; detecting cancer at its earliest stages; and providing access to quality care, including participation in clinical trials.